The new test uses patients’ blood to determine levels of a protein present with heart damage and can help physicians learn if a patient is having a heart attack or has other heart abnormalities.
Timothy Colgan, MD, an interventional cardiologist at the Christus Southeast Texas Cardiology Center in Beaumont, told The Beaumont Enterprise the test has been successful abroad and in tests in research hospitals across the nation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.